Variant report
Variant | esv1803171 |
---|---|
Chromosome Location | chr1:86551864-86556298 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11161729 | chr1:86551864-86551865 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs77294568 | chr1:86551921-86551922 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560039510 | chr1:86551958-86551959 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373384883 | chr1:86551960-86551961 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185181524 | chr1:86551968-86551969 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188087531 | chr1:86551987-86551988 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537169877 | chr1:86551998-86551999 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs118151484 | chr1:86552064-86552065 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550917896 | chr1:86552210-86552211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1507281 | chr1:86552226-86552227 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs10782563 | chr1:86552269-86552270 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs552990861 | chr1:86552333-86552334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12723978 | chr1:86552334-86552335 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs540136972 | chr1:86552351-86552352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372434624 | chr1:86552361-86552362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182015136 | chr1:86552438-86552439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538823381 | chr1:86552537-86552538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558818349 | chr1:86552544-86552545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186248969 | chr1:86552559-86552560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191594957 | chr1:86552640-86552641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs80165623 | chr1:86552655-86552656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6665375 | chr1:86552664-86552665 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs143443746 | chr1:86552672-86552673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs559602524 | chr1:86552744-86552745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183496649 | chr1:86552756-86552757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568274629 | chr1:86552788-86552789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149447803 | chr1:86552868-86552869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148177466 | chr1:86552878-86552879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370575407 | chr1:86552881-86552882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112079526 | chr1:86552913-86552914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115516926 | chr1:86552936-86552937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562201042 | chr1:86552945-86552946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531219755 | chr1:86552957-86552958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370391454 | chr1:86552970-86552971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567795519 | chr1:86553022-86553023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530033705 | chr1:86553040-86553041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547007638 | chr1:86553139-86553140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11161730 | chr1:86553155-86553156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141977422 | chr1:86553170-86553171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12136002 | chr1:86553238-86553239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34168319 | chr1:86553276-86553277 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs538087735 | chr1:86553281-86553282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146632358 | chr1:86553284-86553285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374465803 | chr1:86553288-86553289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182906090 | chr1:86553336-86553337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186932309 | chr1:86553348-86553349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs117439352 | chr1:86553376-86553377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191407677 | chr1:86553379-86553380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183373264 | chr1:86553403-86553404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs573165795 | chr1:86553404-86553405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 16397240 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:86547000-86556800 | Weak transcription | Pancreas | Pancrea |
2 | chr1:86547400-86553600 | Weak transcription | Fetal Lung | lung |
3 | chr1:86550600-86552400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr1:86550800-86552200 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr1:86550800-86552200 | Enhancers | Dnd41 | blood |
6 | chr1:86550800-86570400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr1:86551000-86552000 | Weak transcription | Colon Smooth Muscle | Colon |
8 | chr1:86551200-86552200 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr1:86551200-86552200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr1:86551400-86552000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr1:86551800-86552000 | Flanking Active TSS | GM12878-XiMat | blood |
12 | chr1:86552000-86552200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr1:86552000-86552200 | Enhancers | Colon Smooth Muscle | Colon |
14 | chr1:86552000-86552200 | Enhancers | GM12878-XiMat | blood |
15 | chr1:86552000-86554600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
16 | chr1:86552200-86552400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr1:86553600-86556000 | Strong transcription | Fetal Lung | lung |
18 | chr1:86554200-86554400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr1:86555400-86555600 | Active TSS | HepG2 | liver |
20 | chr1:86555600-86555800 | Flanking Active TSS | HepG2 | liver |
21 | chr1:86556000-86570200 | Weak transcription | Fetal Lung | lung |